Live website intelligence
Adaptimmune (ADAPY)
Adaptimmune is a clinical-stage biopharmaceutical company focused on the development of novel cancer immunotherapy products for cancer patients
Last refresh
Updated 14d ago
Analyst read
Professional
Detected stack
Quick read
How to read adaptimmune.com quickly
adaptimmune.com looks like health & fitness. Traffic signals point to roughly 10.1K monthly visits. Current AI trust scoring is 10/100.
What to do next
- The stack appears to include Unknown.
- Open the Traffic tab if you need audience scale and geography before outreach.
- Open the Business tab if trust, monetization, or positioning is your first decision filter.
Provider Completeness
50/56 fields populated (89%)
Providers with missing fields
View field-level status
visual: 4/4
All expected fields present
meta: 3/3
All expected fields present
seo: 5/5
All expected fields present
dns: 4/4
All expected fields present
ads: 5/5
All expected fields present
publisher: 3/5
Missing: directCount, resellerCount
files: 2/3
Missing: robotsSitemapUrls
traffic: 10/10
All expected fields present
whois: 6/6
All expected fields present
radar: 2/4
Missing: categories, sourceTimestamp
ai: 6/7
Missing: aiAnalysis.visualAnalysis
Why this module matters
Business signals help answer “is this a real opportunity?”
Use the business tab to understand trust, monetization, audience fit, and brand posture before you spend time on outreach, partnerships, or competitive teardown work.
- Trust score and sentiment are your first risk screen.
- Business summary and audience notes speed up qualification.
- Ads and monetization patterns reveal how the site captures value.
Business Intelligence
Business Profile
Adaptimmune is a clinical-stage biopharmaceutical company developing novel cancer immunotherapy treatments, focused on advancing oncology therapies through clinical research and development.
Classification
Trust & Risk
Trust Assessment
Google Ads Transparency
Publisher Monetization
Monetization Signals
IAB Taxonomy
Business Insights
Business Model
Biopharmaceutical R&D (drug development and potential licensing/partnerships) model detected
Trust Level
Low trust with 10/100 score
Audience
Oncology stakeholders including patients and caregivers (informational), clinicians and researchers, biopharma partners, and investors.
Keep exploring
Keep exploring from this report
Good pSEO pages should not strand the visitor. These links keep the journey moving through adjacent directories and comparable live reports.